Mayuresh Joshi, Head Equity at Marketsmith India, mentions the impact of the dollar index drop and potential safeguard duties on the Nifty metal index. He highlights challenges like Chinese steel dumping and Trump tariffs affecting demand. He emphasizes a cautious approach to mid and small-cap stocks, suggesting selective investments for stable earnings growth.
Dr. Reddy’s Laboratories Q1 Results: PAT rises 2% YoY to Rs 1,418 crore, revenue jumps 11%
Dr Reddy’s Laboratories Q1 Results: Pharma major Dr. Reddy’s Laboratories reported a marginal 2% year-on-year (YoY) growth in its consolidated net profit at Rs 1,418